Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Biol Lett ; 15(10): 20190548, 2019 10 31.
Article En | MEDLINE | ID: mdl-31640529

The two Buphagus oxpecker species are specialized passerines that forage for ticks and other food particles on the body of ungulates in the African savannahs. One of their intriguing features is their ability to coexist despite sharing the same, specialized diet. Using co-occurrence data (photographs of giraffes with oxpeckers on them) and approximate Bayesian computing, we demonstrate that yellow-billed oxpeckers changed host faster than red-billed oxpeckers and appeared to displace red-billed oxpeckers from preferred giraffe body parts. Conversely, red-billed oxpeckers exhibited a fuller use of each host and displaced yellow-billed oxpeckers from distal giraffe body parts. These findings highlight that the partition of giraffe hosts in two separate niches was only part of the coexistence story in this species pair. More precisely, the oxpeckers shared the resource by exploiting it at different rates. They engaged in different trade-offs between giving-up density, patch discovery rate and competitor displacement ability. They illustrate the importance of the time frame of interactions.


Giraffes , Starlings , Ticks , Animals , Bayes Theorem , Mammals
2.
Am J Cardiol ; 121(8): 897-902, 2018 04 15.
Article En | MEDLINE | ID: mdl-29452691

The characteristics and predictors of long-term recurrent ischemic cardiovascular events (RICEs) after myocardial infarction with ST-segment elevation (STEMI) have not yet been clarified. We aimed to characterize the 10-year incidence, types, and predictors of RICE. We obtained 10-year follow-up of STEMI survivors at 17 Quebec hospitals in Canada (the AMI-QUEBEC Study) in 2003. There were 858 patients; mean age was 60 years and 73% were male. The majority of patients receive reperfusion therapy; 53.3% and 39.2% of patients received primary percutaneous coronary intervention (PCI) and fibrinolytic therapy, respectively. Seventy-five percent of patients underwent in-hospital PCI (elective, rescue, and primary). At 10 years, 42% of patients suffered a RICE, with most RICEs (88%) caused by recurrent cardiac ischemia. The risk of RICE was the highest during the first year (23.5 per patient-year). At 10 years, the all-cause mortality was 19.3%, with 1/3 of deaths being RICE-related. Previous cardiovascular event, heart failure during the index STEMI hospitalization, discharge prescription of calcium blocker increased the risk of RICE by almost twofold. Each point increase in TIMI (Thrombolysis In Myocardial Infarction) score augmented the risk of RICE by 6%, whereas discharge prescription of dual antiplatelets reduced the risk of RICE by 23%. Our findings suggested that survivors of STEMI remain at high long-term risk of RICE despite high rate of reperfusion therapy and in-hospital PCI. Patients with previous cardiovascular event, in-hospital heart failure, and high TIMI score were particularly susceptible to RICE. Future studies are needed to confirm the impacts of calcium blocker and dual antiplatelets on long-term risk of RICE.


Calcium Channel Blockers/therapeutic use , Heart Failure/epidemiology , Myocardial Ischemia/epidemiology , Percutaneous Coronary Intervention , Platelet Aggregation Inhibitors/therapeutic use , ST Elevation Myocardial Infarction/therapy , Thrombolytic Therapy , Acute Coronary Syndrome/epidemiology , Acute Coronary Syndrome/mortality , Aged , Angina Pectoris/epidemiology , Angina Pectoris/mortality , Carotid Stenosis/epidemiology , Carotid Stenosis/mortality , Cause of Death , Coronary Artery Disease/epidemiology , Coronary Artery Disease/mortality , Drug Therapy, Combination , Female , Heart Aneurysm/epidemiology , Heart Aneurysm/mortality , Humans , Ischemic Attack, Transient/epidemiology , Ischemic Attack, Transient/mortality , Male , Middle Aged , Mortality , Myocardial Infarction/epidemiology , Myocardial Infarction/mortality , Myocardial Ischemia/mortality , Peripheral Arterial Disease/epidemiology , Peripheral Arterial Disease/mortality , Protective Factors , Quebec/epidemiology , Recurrence , Risk Factors , ST Elevation Myocardial Infarction/epidemiology , Stroke/epidemiology , Stroke/mortality , Survivors
3.
J Popul Ther Clin Pharmacol ; 25(2): e63-e77, 2018 11 06.
Article En | MEDLINE | ID: mdl-30725543

Background          Adherence to statins is often sub-optimal and declines over time. Direct costs incurred by patients are frequently cited as responsible for inadequate statin adherence. To determine whether survivors of ST-segment elevation myocardial infarction (STEMI), who benefit from low or no cost drug dispensation, have optimal long-term adherence to statins, we aimed to evaluate the ten-year adherence to statin of these patients. Methods          The AMI-QUEBEC Study follows a cohort of STEMI survivors hospitalized at 17 hospitals in Quebec, Canada during the year 2003. We obtained their 10-year data on lipid lowering therapy (LLT) consumption. Optimal adherence was defined as the proportion of days covered of ≥80%. We used multivariate logistic regression to determine factors independently associated with optimal adherence to statins. Results          Complete 10-year data on statin dispensation was available for 524 patients. Optimal adherence remained stable over time at 80% and more during the 10-year follow-up period. During the last five years, 12% of patients did not use any LLT. Older age, living in less socially deprived areas, concomitant use of angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), and admission to hospitals with percutaneous coronary interventions facilities (PCI-hospitals) were associated with improved statin adherence.   Conclusion Future studies are needed to explore the potential factors associated with concomitant use of ACEI/ARB, and admission to PCI-hospitals that may have optimized statin adherence. Socially deprived patients may benefit from more support and encouragement to enhance their long-term statin adherence.


Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Medication Adherence/statistics & numerical data , ST Elevation Myocardial Infarction/drug therapy , Age Factors , Aged , Aged, 80 and over , Angiotensin Receptor Antagonists/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Cohort Studies , Female , Follow-Up Studies , Hospitalization/statistics & numerical data , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Percutaneous Coronary Intervention/statistics & numerical data , Quebec , Survivors/statistics & numerical data , Time Factors
...